3Lourie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and evaluation of death rate differences between facilities[J]. Am J Kidney Dis 1990,15 : 458-482.
4Dames B, Ducimetiere P[J]. Serum albumin and mortality. Lancent 1990,335 : 350 351
5Fried L, Bemaedini J : Charlson comobidity index as predictor of outcome in incident peritoneal dialysis patients[J]. Am J Kidney Dis, 2001, 37(2):337-342.
6Blagg CR, Liedtke R J, Batjer JD, et al. Serum albumin concentration related health care financing administration quality assurance criterion is method-dependent : Revision is necessary[J]. Am J Kidney Dis 1993,21 : 114-138.
7Leigh C,Ward, S. A. Jebb. Evaluation of a new bioelectrical impedance instrument for the predication of body cell mass independently of height or weight[J]. Nutritional Investigation 2000,16 : 745-750.
8Niebauer J, Volk HD, Kemp M: Endotoxin and immune activation in chronic heart falure: a prospective cohort study[J], Lancet 1999,353 : 1838-1842.
9Kamyar Kalantar-Zadeh,Mark Unruh.Health related quality of life in patients with chronic kidney disease[J].International Urology and Nephrology,2005,(37):367-378.
